Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDH1 | O75874 | 16/20 | 0.32 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18237542 | 0.74 | GSK3B (0.34) | IDH1 | |
| SCHEMBL2669656 | 0.66 | OPRL1 (0.40) | CXCR4 | |
| SCHEMBL25515629 | 0.66 | OPRL1 (0.40) | CXCR4 | |
| SCHEMBL1698240 | 0.63 | CXCR4 (0.45) | CXCR4 | |
| SCHEMBL24402677 | 0.62 | CHRNB2 (0.33) | — | |
| SCHEMBL19131088 | 0.60 | HTR2A (0.35) | CXCR4 | |
| SCHEMBL22966378 | 0.58 | — | — | |
| SCHEMBL22966389 | 0.58 | F2 (0.36) | IDH1 | |
| SCHEMBL25839989 | 0.58 | CXCR4 (0.38) | IDH1CXCR4 | |
| SCHEMBL18237845 | 0.58 | GSK3B (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230000993-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | BLINKBIO INC (US) | 2023-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230000993-A1 | SILICON BASED DRUG CONJUGATES AND METHODS OF USING SAME | CD44, MSN, AS3MT | IDH1 223/4885CXCR4 2552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.